Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Bumetanide for Newborn Seizures: A Phase I Study of Pharmacokinetics and Safety of Bumetanide for Neonatal Seizures

NCT00830531 is registered in ClinicalTrials.gov with Soul, Janet , M.D. as lead sponsor.

NCT NCT00830531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00830531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Bumetanide for Newborn Seizures: A Phase I Study of Pharmacokinetics and Safety of Bumetanide for Neonatal Seizures
Lead sponsor
Soul, Janet , M.D.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2019
Enrollment
43 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

seizures